Cezar Augusto De Oliveira

Cezar Augusto De Oliveira i

Centro de Desenvolvimento da Tecnologia Nuclear - Belo Horizonte / Brazil
Business & Management / Business Administration
AD Scientific Index ID: 4412577
Nuclear Technology Development Center
person_outline Cezar Augusto De Oliveira's MOST POPULAR ARTICLES
1-) Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UKM Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ...The Lancet 397 (10269), 99-111, 202140772021
2-) Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trialPM Folegatti, KJ Ewer, PK Aley, B Angus, S Becker, ...The Lancet 396 (10249), 467-478, 202022602020
3-) Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trialMN Ramasamy, AM Minassian, KJ Ewer, AL Flaxman, PM Folegatti, ...The Lancet 396 (10267), 1979-1993, 202012862020
4-) Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four …M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ...The Lancet 397 (10277), 881-891, 202114072021
5-) QFD: planejamento da qualidadeLC Cheng, CA SCAPIN, CA Oliveira, E Krafetuski, FB Drumond, FS Boan, ...Belo Horizonte: Fundação Christiano Ottoni 262, 19952621995